Lack of a Pharmacokinetic Interaction Between SYM-1219 Granules Containing 2 Grams of Secnidazole and a Combined Oral Contraceptive in a Phase 1, Randomized, Open-Label Study in Healthy Female Volunteers

2016 ◽  
Vol 33 (12) ◽  
pp. 2229-2241 ◽  
Author(s):  
Helen S. Pentikis ◽  
Nikki Adetoro ◽  
Carol J. Braun
Keyword(s):  
Oral Contraceptive ◽  
Phase 1 ◽  
Pharmacokinetic Interaction ◽  
Open Label ◽  
Open Label Study ◽  
Label Study ◽  
Combined Oral Contraceptive ◽  
Healthy Female

Pituitary, ovarian and additional contraceptive effects of an estradiol-based combined oral contraceptive: results of a randomized, open-label study

Contraception ◽  
2013 ◽  
Vol 87 (2) ◽  
pp. 227-234 ◽  
Author(s):  
Jan Endrikat ◽  
Susanne Parke ◽  
Dietmar Trummer ◽  
Marco Serrani ◽  
Ingrid Duijkers ◽  
...  
Keyword(s):  
Oral Contraceptive ◽  
Open Label ◽  
Open Label Study ◽  
Label Study ◽  
Combined Oral Contraceptive

Phase 1 open-label study evaluating the safety, pharmacokinetics, and preliminary efficacy of dilpacimab in patients with advanced solid tumors

2021 ◽  
pp. molcanther.0985.2020
Author(s):  
Michael S. Gordon ◽  
John Nemunaitis ◽  
Minal Barve ◽  
Zev A. Wainberg ◽  
Erika P. Hamilton ◽  
...  
Keyword(s):  
Solid Tumors ◽  
Phase 1 ◽  
Advanced Solid Tumors ◽  
Open Label ◽  
Open Label Study ◽  
Label Study

Abstract C37: A Phase 1 open‐label study evaluating pharmacokinetics, safety, and tolerability of linifanib in Japanese patients with solid tumors

2009 ◽  
Author(s):  
Tomohide Tamura ◽  
Noboru Yamamoto ◽  
Hiroshi Nokihara ◽  
Yasuhide Yamada ◽  
Hajime Asahina ◽  
...  
Keyword(s):  
Solid Tumors ◽  
Phase 1 ◽  
Japanese Patients ◽  
Open Label ◽  
Open Label Study ◽  
Label Study
Sign in / Sign up

Export Citation Format

Share Document